Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Burkitt's lymphoma--a case report].

L Obeid1, B Schär, F Heitzmann

  • 1Medizinische Klinik, Kantonsspital Aarau.

Praxis
|September 29, 1999
PubMed
Summary

Burkitt lymphoma, an aggressive Non-Hodgkin lymphoma, is characterized by c-myc oncogene translocations. Intensive chemotherapy offers an 85-95% cure rate for this rare cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammation reduces the effect of nutritional therapy on clinical outcomes in cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

Hematological oncology·2020
Same author

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Leukemia·2020
Same author

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Leukemia·2020
Same author

Extending shelf life of dithiothreitol-treated panel RBCs to 28 days.

Vox sanguinis·2018

Area of Science:

  • Oncology
  • Genetics
  • Hematology

Background:

  • Burkitt lymphoma is a rare, aggressive form of Non-Hodgkin lymphoma.
  • Diagnosis relies on histology, immunophenotyping, and cytogenetic/molecular analyses.

Observation:

  • Most Burkitt lymphoma cases exhibit a characteristic translocation of the c-myc oncogene.
  • This translocation involves chromosome 8 and immunoglobulin genes on chromosomes 14, 2, or 22.

Findings:

  • The c-myc oncogene translocation is a key molecular hallmark of Burkitt lymphoma.
  • Cytogenetic and molecular techniques are crucial for identifying this specific genetic abnormality.

Implications:

  • Understanding the c-myc translocation aids in accurate diagnosis and classification of Burkitt lymphoma.
  • Effective short-term, intensive chemotherapy regimens achieve high cure rates (85-95%) for affected patients.

Related Experiment Videos